Hepatitis E virus: Emerging from the shadows in developed countries

Transfusion and Apheresis Science

Volumn 55, Issue 3, 2016, Pages 271-274

  Dalton, Harry R ^a   Seghatchian, Jerard ^b  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

Author keywords

Blood products; Epidemiology; Hepatitis E virus (HEV); Pigs; Zoonosis

Indexed keywords

CLINICAL FEATURE; DEVELOPED COUNTRY; ECLAMPSIA; ENDEMIC DISEASE; EPIDEMIC; FETUS WASTAGE; FULMINANT HEPATIC FAILURE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MORTALITY; NONHUMAN; REVIEW; SEROLOGY; THIRD TRIMESTER PREGNANCY; VASCULARIZATION; ANIMAL; BLOOD DONOR; BLOOD TRANSFUSION; GENETICS; PHYSIOLOGY; VIROLOGY;

ANIMALS; BLOOD DONORS; BLOOD TRANSFUSION; DEVELOPED COUNTRIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS;

EID: 85003845915     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.10.016     Document Type: Review

References (33)

1. [1] Kamar, N., Bendall, R., Abravanel, F., Xia, N., Ijaz, S., Izopet, J., et al. Hepatitis E. Lancet 379 (2012), 2477–2488.
2. [2] Dalton, H.R., Bendall, R., Ijaz, S., Banks, M., Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8:11 (2008), 698–709.
3. [3] Guillois, Y., Abravanel, F., Miura, T., Pavio, N., Vaillant, V., Lhomme, S., et al. High proportion of asymptomatic infections in an outbreak of hepatitis e associated with a spit-roasted piglet, France, 2013. Clin Infect Dis 62:3 (2016), 351–357, 10.1093/cid/civ862 26429341.
4. [4] Woolson, K.L., Forbes, A., Vine, L., Beynon, L., McElhinney, L., Panayi, V., et al. Extra-hepatic manifestation of autochthonous hepatitis E infection. Aliment Pharmacol Ther 40 (2014), 1282–1291.
5. [5] Blasco-Perrin, H., Madden, R.G., Stanley, A., Crossan, C., Hunter, J.G., Vine, L., et al. Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study. Aliment Pharmacol Ther 42:5 (2015), 574–581.
6. [6] Kamar, N., Selves, J., Mansuy, J.M., Ouezzani, L., Peron, J.M., Guitard, J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358:8 (2008), 811–817, 10.1056/NEJMoa0706992 18287603.
7. [7] Hewitt, P.E., Ijaz, S., Brailsford, S.R., Brett, R., Dicks, S., Haywood, B., et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384:9956 (2014), 1766–1773.
8. [8] Public Health England, Hepatitis E: symptoms, transmission, treatment and prevention. May; Available from https://www.gov.uk/government/publications/hepatitis-e-symptoms-transmission-prevention-treatment/hepatitis-e-symptoms-transmission-treatment-and-prevention, 2016 Accessed 21 August 16.
9. [9] Dalton, H.R., Fellows, H.J., Stableforth, W., Joseph, M., Thurairajah, P., Warshow, U., et al. The role of HEV testing in drug-induced liver injury. Aliment Pharmacol Ther 26 (2007), 1429–1435.
10. [10] Dalton, H.R., Hepatitis E: the ‘new kid on the block’ or an old friend?. Transfus Med Hemother 41:1 (2014), 6–9.
11. [11] Dalton, H.R., Kamar, N., van Eijk, J.J., McLean, B.N., Cintas, P., Bendall, R.P., et al. Hepatitis E virus and neurological injury. Nat Rev Neurol 12:2 (2016), 77–85.
12. [12] Bendall, R., Ellis, V., Ijaz, S., Ali, R., Dalton, H., A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82 (2010), 799–805.
13. [13] Mansuy, J.M., Bendall, R., Legrand-Abravanel, F., Calot, J.P., Kamar, N., Miedouge, M., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:12 (2011), 2309–2312.
14. [14] Zaaijer, H.L., No artifact, hepatitis E is emerging. Hepatology, 62, 2015, 654.
15. [15] Adlhoch, C., Avellon, A., Baylis, S.A., Ciccaglione, A.R., Couturier, E., de Sousa, R., et al. Hepatitis E virus: assessment of the epidemiological situation in humans in Europe, 2014/15. J Clin Virol 82 (2016), 9–16.
16. [16] Mansuy, J.M., Gallian, P., Dimeglio, C., Saune, K., Arnaud, C., Pelletier, B., et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 63:4 (2016), 1145–1154, 10.1002/hep.28436 27008201.
17. [17] Lucarelli, C., Spada, E., Taliani, G., Chionne, P., Madonna, E., Marcantonio, C., et al. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014. Euro Surveill, 21(30), 2016, 10.2807/1560-7917.
18. [18] Cleland, A., Smith, L., Crossan, C., Blanchard, O., Dalton, H.R., Scobie, L., et al. HEV seroprevalence and HEV RNA presence in plasma minipools of Scottish blood donors. Vox Sang 105 (2013), 283–289.
19. [19] Dalton, H.R., Stableforth, W., Thurairajah, P., Hazeldine, S., Remnarace, R., Usama, W., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 20:8 (2008), 784–790, 10.1097/MEG.0b013e3282f5195a 18617784.
20. [20] Hogema, B.M., Molier, M., Slot, E., Zaaijer, H.L., Past and present of hepatitis E in the Netherlands. Transfusion 54:12 (2014), 3092–3096, 10.1111/trf.12733 24889277 PubMed Central PMCID: PMCPMC4280434.
21. [21] Crossan, C., Baker, P.J., Craft, J., Takeuchi, Y., Dalton, H.R., Scobie, L., Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 18 (2012), 2085–2087.
22. [22] Brassard, J., Gagne, M.J., Genereux, M., Cote, C., Detection of human food-borne and zoonotic viruses on irrigated, field-grown strawberries. Appl Environ Microbiol 78 (2012), 3763–3766.
23. [23] Hartl, J., Otto, B., Madden, R.G., Webb, G., Woolson, K.L., Kriston, L., et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses, 8(8), 2016, 10.3390/v8080211 pii: E211.
24. [24] Huang, F., Li, Y., Yu, W., Jing, S., Wang, J., Long, F., et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis. Hepatology 64:2 (2016), 350–359, 10.1002/hep.28668 27286751.
25. [25] Slot, E., Hogema, B.M., Riezebos-Brilman, A., Kok, T.M., Molier, M., Zaaijer, H.L., Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill, 18(31), 2013, 20550.
26. [26] Fischer, C., Hofmann, M., Danzer, M., Hofer, K., Kaar, J., Gabriel, C., Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS ONE, 10, 2015, e0119576.
27. [27] Stramer, S.L., Moritz, E.D., Foster, G.A., Ong, E., Linnen, J.M., Hogema, B.M., et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 56:2 (2015), 481–488.
28. [28] Vollmer, T., Diekmann, J., Johne, R., Eberhardt, M., Knabbe, C., Dreier, J., Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 50 (2012), 2708–2713.
29. [29] Fukuda, S., Sunaga, J., Saito, N., Fujimura, K., Itoh, Y., Sasaki, M., et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol 73 (2004), 554–561.
30. [30] Gallian, P., Lhomme, S., Piquet, Y., Saune, K., Abravanel, F., Assal, A., et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 20 (2014), 1914–1917.
31. [31] Baylis, S.A., Gartner, T., Nick, S., Ovemyr, J., Blümel, J., Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 103 (2012), 89–90.
32. [32] Kamar, N., Dalton, H.R., Abravanel, F., Izopet, J., Hepatitis E virus infection. Clin Microbiol Rev 27:1 (2014), 116–138, 10.1128/CMR.00057-13.
33. [33] Mallet, V., Sberro-Soussan, R., Vallet-Pichard, A., Roque-Afonso, A.M., Pol, S., Transmission of hepatitis e virus by plasma exchange: a case report. Ann Intern Med 164:12 (2016), 851–852, 10.7326/L15-0502.